Skip to main navigation
Go to Nurix Therapeutics, Inc. homepage
Nurix Therapeutics, Inc.
  • Inside The Science
    • DEL-AI Discovery Engine
    • Targeted Protein Degradation
    • Resource Library
  • Advancing Our Pipeline
    • Pipeline
    • Clinical Trials
  • Learn About Us
    • Our Story
    • Leadership
    • Partnering
    • Contact Us
  • Work at Nurix
    • Our Culture
    • Explore Jobs
For Patients
 For Patients
For Investors
 For Investors
Go to Nurix Therapeutics, Inc. homepage
Nurix Therapeutics, Inc.
  • Inside The Science
    • DEL-AI Discovery Engine
    • Targeted Protein Degradation
    • Resource Library
  • Advancing Our Pipeline
    • Pipeline
    • Clinical Trials
  • Learn About Us
    • Our Story
    • Leadership
    • Partnering
    • Contact Us
  • Work at Nurix
    • Our Culture
    • Explore Jobs

FOR INVESTORS

Event details

  • Overview
  • Press Releases
  • Events
  • Financial Info
  • Stock
  • Governance
  • FAQs

Discussion of Initial NX-2127 Phase 1a PK/ PD Data

October 27, 2021 8:30 AM EDT

View Webcast
Print Page (opens in new tab)

Print Page

Contact IR (opens in new tab)

Contact IR

RSS (opens in new tab)

RSS

Email Alerts (opens in new tab)

Email Alerts

Go to Nurix Therapeutics, Inc. homepage

WHERE SCIENCE EXPANDS POSSIBILITIES

Inside The Science

  • DEL-AI Discovery Engine
  • Targeted Protein Degradation
  • Resource Library

Advancing Our Pipeline

  • Pipeline
  • Clinical Trials

Learn About Us

  • Our Story
  • Leadership
  • Partnering
  • Contact Us

Work at Nurix

  • Our Culture
  • Explore Jobs

For Investors

  • News
  • Financial Information
  • Stock Information
  • Corporate Governance
  • FAQs
  • Investor Contact

For Patients

  • Resources

©2025 Nurix Therapeutics, Inc.

Privacy Policy

Terms of Use

Cookie Policy

Privacy Policy

Terms of Use

Cookie Policy